| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2003 | EP1317262A1 Topically applied hoof treatment composition concentrate |
| 06/11/2003 | EP1317260A2 Methods for treating tumors using sulfonyl compounds |
| 06/11/2003 | EP1317259A2 Prevention of acute sinusitis and sinus attack |
| 06/11/2003 | EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease |
| 06/11/2003 | EP1317256A2 Pharmaceutical composition having modified carrier |
| 06/11/2003 | EP1317252A2 Pharmaceutical composition having specific water activity |
| 06/11/2003 | EP1317238A1 Compositions containing a vitamin c component and pigment |
| 06/11/2003 | EP1317226A1 Treatment of human herpesviruses using hyperthermia |
| 06/11/2003 | EP1317188A2 Animal feed,feed additive and therapeutic agent against intestinal inflammation |
| 06/11/2003 | EP1317187A2 Feedstuff or a feedstuff additive used as a performance promoter or as an appetite promoter for domestic animals |
| 06/11/2003 | EP1267976A4 Microencapsulated fragrances and methods of coating microcapsules |
| 06/11/2003 | EP1248637A4 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity |
| 06/11/2003 | EP1228077B1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 06/11/2003 | EP1156828B1 Combination therapy for lymphoproliferative diseases |
| 06/11/2003 | EP1148884A4 Graduated progestin contraceptive |
| 06/11/2003 | EP1133307B1 Use of a composition comprising soy protein, dietary fibres and a phytoestrogen compound in the prevention and/or treatment of pulmonary diseases |
| 06/11/2003 | EP1131065B1 Dialkylfumarates for the treatment of autoimmune diseases |
| 06/11/2003 | EP1060161B1 Matrix metalloproteinase inhibitors |
| 06/11/2003 | EP1054012B1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| 06/11/2003 | EP1039891A4 Treatment of scar tissue using lipoic acid |
| 06/11/2003 | EP1024810A4 Method for optimizing retinal and optic nerve health |
| 06/11/2003 | EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 06/11/2003 | EP1011683A4 Vitamin d analogues and their neuronal effects |
| 06/11/2003 | EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 06/11/2003 | EP0981341B1 Use of betulinic acid derivatives for the treatment and prevention of melanoma |
| 06/11/2003 | EP0973741B1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 06/11/2003 | EP0966462B1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 06/11/2003 | EP0950053B1 New derivatives of benzoylalkyl-1,2,3,6-tetrahydropyridins |
| 06/11/2003 | EP0938325B1 Methods for sterilizing male mammals |
| 06/11/2003 | EP0910382B1 Squalamine in combination with other anti-cancer agents for treating tumors |
| 06/11/2003 | EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use |
| 06/11/2003 | EP0879051B1 Rate-controlled transdermal administration of risperidone |
| 06/11/2003 | EP0848755B1 Vegf-related protein |
| 06/11/2003 | EP0821586B1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 06/11/2003 | EP0810855B1 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 06/11/2003 | EP0758230B1 Use of steroid sulphatase inhibitors |
| 06/11/2003 | EP0638119B1 Chimeric receptor genes and cells transformed therewith |
| 06/11/2003 | EP0611301B1 Chelator compositions comprising oxime compounds |
| 06/11/2003 | CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof |
| 06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
| 06/11/2003 | CN1423695A Antisense oligonucleotides |
| 06/11/2003 | CN1423693A Method for the production of vitamin A |
| 06/11/2003 | CN1423658A Modulation of human sodium channels in dorsal root ganglia |
| 06/11/2003 | CN1423657A Inter feron-alpha induced gene |
| 06/11/2003 | CN1423655A Novel lipopeptides as antibacterial agents |
| 06/11/2003 | CN1423651A New use and novel N-azabicyclo-amide derivatives |
| 06/11/2003 | CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand |
| 06/11/2003 | CN1423648A 1-(H-1,2,4-triazol-1-yl) butan-2-ol derivatives |
| 06/11/2003 | CN1423647A Beta-alanine derivatives and their use as receptor antagonists |
| 06/11/2003 | CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/11/2003 | CN1423645A 维他命d类似物 Vitamin d analogues |
| 06/11/2003 | CN1423644A Method for the preparation of citalopram |
| 06/11/2003 | CN1423642A Oxy-and amino-substituted tetrahydrofurl derivatives with antitumour activity |
| 06/11/2003 | CN1423641A Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/11/2003 | CN1423640A 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 06/11/2003 | CN1423639A Solid state forms of 5-[[6-[(2-Fluorophenyl) methoxy]-2-naphthalenyl] methyl]-2,4-Thiazolidinedione |
| 06/11/2003 | CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors |
| 06/11/2003 | CN1423635A Nitrogenous compounds and antiviral drugs containing the same |
| 06/11/2003 | CN1423634A Polymorphic form of atorvastain calcium |
| 06/11/2003 | CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions |
| 06/11/2003 | CN1423630A Quaternary ammonium compounds and their use as anti-tussive agents |
| 06/11/2003 | CN1423627A 维生素d类似物 Vitamin d analogues |
| 06/11/2003 | CN1423566A 体重增加抑制剂 Weight gain inhibitor |
| 06/11/2003 | CN1423564A APLIDINE treatment of cancers |
| 06/11/2003 | CN1423563A Pancreatic stem cells and their use in transplantation |
| 06/11/2003 | CN1423562A Perfusion liquid preparations for ophthalmic operations |
| 06/11/2003 | CN1423561A Remedies for hepatitis C |
| 06/11/2003 | CN1423560A Male contraceptive formulation comprising norethisterone |
| 06/11/2003 | CN1423559A Controlled-release compositions containing opioid agonist and antagonist |
| 06/11/2003 | CN1423558A Novel processes for preparing torsemide intermediate |
| 06/11/2003 | CN1423557A Intracorporeal medicaments for photodynamic treatment of disease |
| 06/11/2003 | CN1423556A Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 06/11/2003 | CN1423555A 掩蔽味道的涂料组合物 Taste-masking coating composition |
| 06/11/2003 | CN1423550A Cosmetic compositions containing chick pea extract and retinoids |
| 06/11/2003 | CN1423528A Nutritional modules |
| 06/11/2003 | CN1422862A 3,6 branched manno oligose structure used as medicine and its preparation method |
| 06/11/2003 | CN1422861A Use of saponin |
| 06/11/2003 | CN1422859A Reaction method of biological alkali, reaction product and use thereof |
| 06/11/2003 | CN1422851A Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease |
| 06/11/2003 | CN1422850A Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use |
| 06/11/2003 | CN1422849A 吲唑衍生物 Indazole derivative |
| 06/11/2003 | CN1422667A Oral liquor composition with reduced bitter taste |
| 06/11/2003 | CN1422663A Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method |
| 06/11/2003 | CN1422653A Effective part of root of red-rooted salvia and compound powder injecta of root of red-rooted salvia and preparation method and use of said medicine |
| 06/11/2003 | CN1422652A Chinese medicinal preparation for treating gynaecology disease of cervicitis |
| 06/11/2003 | CN1422650A Ointment for treating various skin diseases and preparation method thereof |
| 06/11/2003 | CN1422623A Chinese medicine composite external for treating alopecia areata and its preparation method |
| 06/11/2003 | CN1422622A Herba-Epimedii extract for treating prostatic hyerplasia and use in preparing medicine |
| 06/11/2003 | CN1422621A 1-calcium phosphate-uracil medicine and preparation method |
| 06/11/2003 | CN1422620A Aerosol for treating poisoning by nitrogen oxide and its use and preparation method |
| 06/11/2003 | CN1422619A Lipid composition of high non-soluble platinum matches and lipid body |
| 06/11/2003 | CN1422618A 9-nitrocamptothecin solid dispersant and preparation method |
| 06/11/2003 | CN1422617A Integerrimine liposome gel preparation and preparing method |
| 06/11/2003 | CN1422616A Use of hydroxy saflor yellow pigment A in preparing medicine for treating and preventing cardiovascular and cerebrovascular disease |
| 06/11/2003 | CN1422615A Diacetylamino-acetoxy-ethylenediamine larg-volume injecta and preparation method thereof |
| 06/11/2003 | CN1422614A Soluble L-calcium lactate preparation and preparing method |
| 06/11/2003 | CN1422612A Nano-grade medicine controlled-releasing technology and preparation and use for viformicoid preparation |
| 06/11/2003 | CN1422611A Albendazole lipid and method for preparing said lipid by neutralization method |
| 06/11/2003 | CN1111162C Artemisinin derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 06/11/2003 | CN1111160C Dibenzylisoquinoline alkaloids and medicinal composition and its use |